Laura Turco
@Laura_Turco83
Followers
486
Following
842
Statuses
316
MD, PhD. Transplant Hepatologist
Bologna, Emilia Romagna
Joined April 2018
Thanks to you for involving me @a_zanetto and @marcosenzolo!
First cirrhosis-specific model for predicting the risk of VTE in hospitalized patients with cirrhosis. Thanks to all coauthors. @UEGJournal @marcosenzolo @Vaital73 @AisfFegato
0
0
4
Original Article Diagnostic accuracy of 2D-SWE ultrasound for liver fibrosis assessment in MASLD: A multi-level random effects model meta-analysis Taru et al. #LiverX
0
0
3
RT @BavenoCoop: ❓How can we go beyond binary outcomes in assessing treatment effects in ACLD? 💡Learn about hierarchical outcomes, recurre…
0
9
0
@GiadaSebastiani @JHepatology @EASLnews @CASLupdates @McGill_DOM @CanMASLDNetwork @RIMUHC1 @IDIGHProgram @CIHR_CTN Congratulations @GiadaSebastiani! Well deserved!
1
0
1
RT @BavenoCoop: 🎄 Wishing everyone a Merry Christmas and Happy Holidays from all of us at @BavenoCoop ‼️ ✨ Here's to a joyful season and a…
0
5
0
RT @JIFortea: 🚨 It is finally here‼️ 📜 Carvedilol vs. Propranolol for preventing decompensation and mortality in compensated & decompensat…
0
134
0
RT @BavenoCoop: 🚨Be aware @BavenoCoop members!! 🗓️TODAY is the virtual General Assembly at 17:00 PM (CEST) ⛓️💥Zoom link sent to all mem…
0
4
0
RT @BavenoCoop: 🚨Don’t miss the Baveno VIII Pre-Symposium Webinar: Designing Clinical Studies in Advanced Chronic Liver Disease A must-a…
0
24
0
RT @AisfFegato: Si è aperto oggi a Roma il 4° "AISF Training Day" della Scuola di Epatologia AISF, dal titolo "Bedside Approach and Precisi…
0
3
0
RT @JHEP_Reports: 🟪NEW Article in press❕ Liver transplantation for HBV-related liver disease: impact of prophylaxis for HBV on HCC recurre…
0
13
0
RT @BavenoCoop: Join the @BavenoCoop family to: 1️⃣ Stay updated on #PortalHypertension 2️⃣ Participate in studies 3️⃣ Young/experienced m…
0
8
0
What a news from @LiverInt! 🥳 Our review on CARVEDILOL IN PORTAL HYPERTENSION has received over 20,000 views since publication! 🥰 @ReibergerThomas @VincenzoLaMura @GiovanniVitale 🔽 #ViewsMilestone
0
6
47
Check-out our last article! 🔽 β-blockers lower first decompensation in patients with cirrhosis and enduring portal hypertension after etiological treatment. @MadalinaTaru
@horstef
@bogdanprocopet
@BavenoCoop
2
22
57
RT @jcgarciapagan: Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome. - Journal of H…
0
43
0
RT @RautouE: 📢🆕 @ValdigGroup study just out in @HEP_Journal Want to spare endoscopies in patients with PSVD❓ Spleen stiffness measur…
0
13
0
0
0
2
@docberza @JHepatology @EASLnews @MedFacultyUniBE @inselgruppe Congratulations @docberza! Well deserved!
0
0
1